Casdin Capital’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$166M Sell
7,707,165
-1,000,000
-11% -$21.5M 15.12% 2
2025
Q1
$199M Hold
8,707,165
16.25% 2
2024
Q4
$226M Hold
8,707,165
15.04% 2
2024
Q3
$218M Hold
8,707,165
14.54% 1
2024
Q2
$187M Hold
8,707,165
14.25% 1
2024
Q1
$162M Hold
8,707,165
12.01% 3
2023
Q4
$141M Buy
8,707,165
+927,165
+12% +$15.1M 13.89% 2
2023
Q3
$107M Buy
7,780,000
+58,465
+0.8% +$807K 11.89% 2
2023
Q2
$171M Buy
7,721,535
+150,000
+2% +$3.32M 14.91% 1
2023
Q1
$165M Buy
7,571,535
+5,243
+0.1% +$114K 13.57% 1
2022
Q4
$138M Hold
7,566,292
10.67% 2
2022
Q3
$172M Hold
7,566,292
11.31% 2
2022
Q2
$104M Hold
7,566,292
8.83% 3
2022
Q1
$172M Hold
7,566,292
7.71% 1
2021
Q4
$282M Hold
7,566,292
7.95% 1
2021
Q3
$320M Buy
7,566,292
+126,185
+2% +$5.34M 7.97% 2
2021
Q2
$331M Hold
7,440,107
8.41% 2
2021
Q1
$268M Hold
7,440,107
7.98% 4
2020
Q4
$297M Buy
7,440,107
+1,600,000
+27% +$63.8M 8.79% 2
2020
Q3
$169M Buy
5,840,107
+990,583
+20% +$28.7M 7.57% 2
2020
Q2
$79.3M Buy
4,849,524
+2,380,953
+96% +$38.9M 4.69% 7
2020
Q1
$23.5M Hold
2,468,571
2.49% 16
2019
Q4
$39.9M Buy
2,468,571
+40,000
+2% +$647K 3.67% 12
2019
Q3
$40.4M Hold
2,428,571
4.18% 10
2019
Q2
$39.4M Hold
2,428,571
3.69% 12
2019
Q1
$43.4M Hold
2,428,571
4.77% 9
2018
Q4
$29.2M Hold
2,428,571
5% 9
2018
Q3
$42.5M Buy
2,428,571
+1,428,571
+143% +$25M 5.17% 6
2018
Q2
$11.4M Buy
+1,000,000
New +$11.4M 1.6% 21